Moving at warp speed: Are you ready to go to market?

The current model for biotech companies often means operating in drastically compacted timelines. This focus on speed can lead to complications or oversight of important regulatory and intellectual property (IP) issues when seeking funding, whether a company is looking to close a seed round or go public.

As you start preparing for JP Morgan's Annual Healthcare Conference, don't miss this opportunity to hear perspectives from members of the Hogan Lovells IP and Global Regulatory teams, the Boston Business Journal, and Larry Shumway from Flagship Pioneering as we share actionable insights on equipping your company with critical knowledge, including:

  • What are the key IP and regulatory issues companies should be on top of before seeking funding?
  • How to best prepare for diligence to avoid holdups?
  • Do you have the right partners and manufacturers to be able to scale up through clinical trials?
  • How do investors value clinical trial data integrity concerns?

Learn More: Moving at warp speed: Are you ready to go to market?


Back To Listing
Loading data